Latest news
25 items- SECSEC Form 8-K filed by Baudax Bio Inc.8-K - Baudax Bio, Inc. (0001780097) (Filer)
- SECSEC Form 25-NSE filed by Baudax Bio Inc.25-NSE - Baudax Bio, Inc. (0001780097) (Subject)
- 13D/GSEC Form SC 13G/A filed by Baudax Bio Inc. (Amendment)SC 13G/A - Baudax Bio, Inc. (0001780097) (Subject)
- 13D/GSEC Form SC 13G/A filed by Baudax Bio Inc. (Amendment)SC 13G/A - Baudax Bio, Inc. (0001780097) (Subject)
- SECBaudax Bio Inc. filed SEC Form 8-K: Other Events8-K - Baudax Bio, Inc. (0001780097) (Filer)
- NEWSCORRECTION: BioCryst Pharmaceuticals Ticker is "BCRX
- NEWSBioCryst Pharmaceuticals Updated Its Agreement With Torii Pharmaceutica For ORLADEYO In Japan; BioCryst Japan K.K. Responsible For All Commercial Promotion Activities And Torii Will Be Responsible For Hereditary Angioedema Disease Awareness Activities-SEC Filing
- SECSEC Form 424B3 filed by Baudax Bio Inc.424B3 - Baudax Bio, Inc. (0001780097) (Filer)
- SECSEC Form 10-Q filed by Baudax Bio Inc.10-Q - Baudax Bio, Inc. (0001780097) (Filer)
- SECSEC Form NT 10-Q filed by Baudax Bio Inc.NT 10-Q - Baudax Bio, Inc. (0001780097) (Filer)
- NEWS12 Health Care Stocks Moving In Wednesday's After-Market SessionGainers Bone Biologics (NASDAQ:BBLG) stock moved upwards by 56.0% to $0.81 during Wednesday's after-market session. Today's trading volume for this security ended up closing at 2.3 million shares, which is 878.8 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $2.5 million. The company's, Q3 earnings came out yesterday. Exagen (NASDAQ:XGN) stock rose 15.78% to $1.76. The market value of their outstanding shares is at $29.6 million. As per the press release, Q3 earnings came out 2 days ago. PAVmed (NASDAQ:PAVM) shares increased by 11.31% to $0.25. The company's market cap stands at $27.4 million. As per the news, the Q3 earnings repor
- SECBaudax Bio Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - Baudax Bio, Inc. (0001780097) (Filer)
- NEWS12 Health Care Stocks Moving In Monday's Pre-Market SessionGainers Celldex Therapeutics (NASDAQ:CLDX) stock increased by 30.1% to $33.8 during Monday's pre-market session. The company's market cap stands at $1.5 billion. As per the press release, Q3 earnings came out 2 days ago. Sensei Biotherapeutics (NASDAQ:SNSE) shares moved upwards by 21.15% to $0.84. The company's market cap stands at $22.2 million. Baudax Bio (NASDAQ:BXRX) shares rose 14.4% to $0.25. The company's market cap stands at $2.3 million. CervoMed (NASDAQ:CRVO) shares moved upwards by 14.17% to $12.48. The market value of their outstanding shares is at $70.8 million. Repare Therapeutics (NASDAQ:RPTX) stock increased by 13.38% to $4.32. The market value of their outstanding share
- SECSEC Form 8-K filed by Baudax Bio Inc.8-K - Baudax Bio, Inc. (0001780097) (Filer)
- NEWSWhy Nuvve Holding Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionGainers Shift Technologies, Inc. (NASDAQ:SFT) shares climbed 107.8% to $0.2239. Shift Technologies recently said it will file for Chapter 11 bankruptcy protection. Treasure Global Inc. (NASDAQ:TGL) climbed 65.1% to $0.5150 after the company announced an AI robot designed to conduct extended-hour live commerce sessions on TikTok. SeaStar Medical Holding Corporation (NASDAQ:ICU) shares climbed 45.3% to $0.6589 after the FDA granted the company’s Selective Cytopheretic Device Breakthrough Device Designation for hepatorenal syndrome. RVL Pharmaceuticals plc (NASDAQ:RVLP) shares gained 31.4% to $0.0670 after falling 12% on Tuesday. RVL Pharmaceuticals said on Oct. 12, the company receive
- NEWS12 Health Care Stocks Moving In Wednesday's Pre-Market SessionGainers Biocept (NASDAQ:BIOC) stock moved upwards by 48.9% to $0.76 during Wednesday's pre-market session. The company's market cap stands at $1.9 million. RVL Pharmaceuticals (NASDAQ:RVLP) stock moved upwards by 47.05% to $0.07. The market value of their outstanding shares is at $8.3 million. Baudax Bio (NASDAQ:BXRX) shares moved upwards by 42.49% to $0.28. The market value of their outstanding shares is at $2.6 million. SeaStar Medical Holding (NASDAQ:ICU) shares rose 19.05% to $0.54. The market value of their outstanding shares is at $10.4 million. Synaptogenix (NASDAQ:SNPX) stock moved upwards by 16.31% to $0.37. The market value of their outstanding shares is at $3.7 million. Yiel
- NEWSBaudax Bio Announces Corporate Update; Co. Says Phase 1/2a Clinical Study Of TI-168 In Hemophilia A with FVIII Inhibitors Projected To Begin In Q1 2024
- PRBaudax Bio Announces Corporate UpdateCompany Poised to Initiate TI-168 Clinical Development Following Recent Shareholder Approval of Corporate Actions Related to TeraImmune Acquisition Phase 1/2a Clinical Study of TI-168 In Hemophilia A with FVIII Inhibitors Projected to Begin Q1 2024 MALVERN, Pa., Oct. 18, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the "Company" or "Baudax Bio") (NASDAQ:BXRX), a biotechnology company focused on developing T cell receptor ("TCR") therapies utilizing human regulatory T cells ("Tregs"), as well as a portfolio of clinical stage Neuromuscular Blocking Agents ("NMBs") and an associated reversal agent, today announced that following recent shareholder approval of corporate actions related to
- SECSEC Form 8-K filed by Baudax Bio Inc.8-K - Baudax Bio, Inc. (0001780097) (Filer)
- INSIDERSEC Form 3 filed by new insider Mcandrew Natalie3 - Baudax Bio, Inc. (0001780097) (Issuer)
- NEWS12 Health Care Stocks Moving In Wednesday's Intraday SessionGainers Tempest Therapeutics (NASDAQ:TPST) stock rose 1642.4% to $4.18 during Wednesday's regular session. The current volume of 141.8 million shares is 24870.9% of Tempest Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $55.6 million. Phio Pharma (NASDAQ:PHIO) shares increased by 55.74% to $2.16. Trading volume for Phio Pharma's stock is 41.3 million as of 13:30 EST. This is 165963.8% of its average full-day volume over the last 100 days. The company's market cap stands at $4.8 million. PaxMedica (NASDAQ:PXMD) shares increased by 32.71% to $0.29. As of 13:30 EST, this security is trading at a volume of 3.5 mill
- NEWSWhy Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionGainers Tempest Therapeutics, Inc. (NASDAQ:TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in first-line hepatocellular carcinoma study. Phio Pharmaceuticals Corp. (NASDAQ:PHIO) jumped 59.5% to $2.17. Phio Pharmaceuticals presented new data for targeting of BRD4 with its INTASYL™ compound PH-894. Tupperware Brands Corporation (NYSE:TUP) surged 42.5% to $2.14. Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) gained 41.4% to $1.2586 after falling 7% on Tuesday. ReTo Eco-Solutions, Inc. (NASDAQ:RETO) jumped 37.3% to $0.7461. Gaucho Group Holdings, Inc. (NASDAQ:VINO) shares climbed 3
- SECSEC Form DEFA14A filed by Baudax Bio Inc.DEFA14A - Baudax Bio, Inc. (0001780097) (Filer)
- NEWSOn October 5, Baudax Bio Appointed Natalie McAndrew As Interim CFO, Effective Immediately. She Will Also Assume The Duties Of The Principal Financial Officer, Principal Accounting Officer, As Jillian Dilmore Announced To Resign Effective October 9- 8Khttps://www.sec.gov/ix?doc=/Archives/edgar/data/1780097/000119312523251966/d416304d8k.htm
- SECSEC Form 8-K filed by Baudax Bio Inc.8-K - Baudax Bio, Inc. (0001780097) (Filer)
BXRX FAQ
5 questionsWhat does Baudax Bio Inc. do?
Baudax Bio, Inc., a pharmaceutical company, develops and commercializes products for hospital and other acute care settings. The company offers ANJESO (meloxicam) injection for the management of moderate to severe pain, alone or in combination with non-NSAID analgesics. Its products under development includes BX1000, an intermediate-acting neuromuscular blocking agent (NMBA) that is in phase I clinical trial; BX2000, an ultrashort-acting NMBA, which is in pre-clinical trial; and BX3000, an NMBA reversal agent, which is under pre-clinical trial, as well as Dex-IN, a proprietary intranasal...Where does BXRX stock trade?
Baudax Bio Inc. (BXRX) is listed on NASDAQ.What sector and industry is BXRX in?
Baudax Bio Inc. operates in the Health Care sector, Misc Health and Biotechnology Services industry.What companies are similar to BXRX?
Notable peers in the same industry include DVA (DaVita Inc.), FMS (Fresenius Medical Care AG), SHC (Sotera Health Company), PGNY (Progyny Inc.), AGL (agilon health inc.). Compare BXRX side-by-side with any of them on Quantisnow.How can I track BXRX on Quantisnow?
Quantisnow aggregates Baudax Bio Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BXRX to receive live email and push alerts on every new disclosure.